This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: D.t.r. Dermal Therapy Research Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Alejandro Fernandez Schrunder: Innovator in Glucose Sensing Technology
Introduction
Alejandro Fernandez Schrunder is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of medical technology, particularly in the development of implantable devices for glucose monitoring. His innovative approach has the potential to improve the quality of life for individuals managing diabetes.
Latest Patents
Alejandro holds a patent for an implantable glucose sensor. This advanced device features a housing that contains two injecting electrodes for delivering current into the tissue and two sensing electrodes for measuring impedance in the tissue. The sensor is powered by a coil within the housing, which connects to a circuit board that integrates the electrodes and a communication unit for data transmission. The design ensures that the electrodes are flush with the outer surface of the housing, which is convex in shape, enhancing its functionality and comfort for the user.
Career Highlights
Alejandro is associated with D.t.r. Dermal Therapy Research Inc., where he continues to work on innovative solutions in dermal therapy and medical devices. His expertise in the field has led to advancements that bridge technology and healthcare, making a significant impact on patient care.
Collaborations
Throughout his career, Alejandro has collaborated with talented professionals such as Stig Ollmar and Ana Rusu. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies.
Conclusion
Alejandro Fernandez Schrunder is a pioneering inventor whose work in implantable glucose sensors exemplifies the intersection of technology and healthcare. His contributions are paving the way for more effective diabetes management solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile